Holen Sie sich die Stockscreener-App
111.25
5.53%
5.83
Handel nachbörslich:
111.42
0.17
+0.15%
Schlusskurs vom Vortag:
$105.42
Offen:
$105.79
24-Stunden-Volumen:
2.82M
Relative Volume:
1.05
Marktkapitalisierung:
$14.02B
Einnahmen:
$692.26M
Nettoeinkommen (Verlust:
$-512.41M
KGV:
-26.24
EPS:
-4.24
Netto-Cashflow:
$-274.36M
1W Leistung:
+15.31%
1M Leistung:
+54.19%
6M Leistung:
+192.76%
1J Leistung:
+240.74%
1-Tages-Spanne:
$104.35
$111.91
1-Wochen-Bereich:
$94.05
$111.91
52-Wochen-Spanne:
$29.91
$111.91
Guardant Health Inc Stock (GH) Company Profile
Firmenname
Guardant Health Inc
Sektor
Branche
Telefon
855-698-8887
Adresse
3100 HANOVER STREET, PALO ALTO
Vergleichen Sie GH mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GH
Guardant Health Inc
|
111.25 | 13.69B | 692.26M | -512.41M | -274.36M | -4.24 |
|
TMO
Thermo Fisher Scientific Inc
|
586.07 | 220.72B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
226.98 | 160.62B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
752.14 | 57.96B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
153.60 | 42.88B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
228.18 | 38.30B | 15.90B | 1.28B | 2.21B | 7.2842 |
Guardant Health Inc Stock (GH) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-25 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-09-22 | Fortgesetzt | Wells Fargo | Overweight |
| 2025-04-10 | Eingeleitet | Mizuho | Outperform |
| 2025-01-23 | Eingeleitet | Barclays | Overweight |
| 2024-06-28 | Hochstufung | Guggenheim | Neutral → Buy |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-04-24 | Fortgesetzt | Craig Hallum | Buy |
| 2023-12-14 | Eingeleitet | Guggenheim | Neutral |
| 2023-12-13 | Eingeleitet | Wolfe Research | Peer Perform |
| 2023-11-13 | Hochstufung | Raymond James | Mkt Perform → Outperform |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-27 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-07-05 | Fortgesetzt | JP Morgan | Overweight |
| 2023-05-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-05-05 | Eingeleitet | UBS | Buy |
| 2023-03-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Outperform |
| 2022-11-01 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-10-19 | Eingeleitet | Craig Hallum | Buy |
| 2022-10-06 | Eingeleitet | Stephens | Overweight |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-06-03 | Eingeleitet | Piper Sandler | Overweight |
| 2022-04-28 | Fortgesetzt | BTIG Research | Buy |
| 2022-02-24 | Bestätigt | Canaccord Genuity | Buy |
| 2022-02-24 | Bestätigt | Citigroup | Buy |
| 2022-02-24 | Bestätigt | Cowen | Outperform |
| 2022-02-24 | Bestätigt | Morgan Stanley | Overweight |
| 2022-02-24 | Bestätigt | SVB Leerink | Outperform |
| 2022-02-24 | Bestätigt | Stifel | Buy |
| 2022-02-24 | Bestätigt | Wells Fargo | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-06-15 | Eingeleitet | Raymond James | Mkt Perform |
| 2021-06-03 | Eingeleitet | Goldman | Buy |
| 2021-05-25 | Eingeleitet | Wells Fargo | Overweight |
| 2021-01-11 | Eingeleitet | Stifel | Buy |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-06-12 | Eingeleitet | BTIG Research | Buy |
| 2020-02-21 | Eingeleitet | Guggenheim | Buy |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-08-07 | Bestätigt | Canaccord Genuity | Buy |
| 2019-04-16 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-04-10 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-02-28 | Bestätigt | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | BofA/Merrill | Neutral |
| 2018-10-29 | Eingeleitet | JP Morgan | Overweight |
| 2018-10-29 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Guardant Health Inc Aktie (GH) Neueste Nachrichten
Alignment Healthcare, Hims & Hers Health, Surgery Partners, Guardant Health, and Pediatrix Medical Group Stocks Trade Up, What You Need To Know - Finviz
Tumor Blood Testing Market Projections 2025-2032: Key Trends, - openPR.com
Guardant Health (GH): Buy, Sell, or Hold Post Q3 Earnings? - TradingView
Insulet, Guardant Health, agilon health, Evolent Health, and Myriad Genetics Stocks Trade Up, What You Need To Know - Yahoo Finance
Oncology Biomarker Market Accelerates Toward USD 113.5 Billion by 2034 - GlobeNewswire Inc.
Will Guardant Health Inc. (5GH) stock gain from green policiesTrend Reversal & Risk Adjusted Buy/Sell Alerts - newser.com
What risks investors should watch in Guardant Health Inc. stock2025 Price Targets & Real-Time Price Movement Reports - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Musa Tariq Sells Shares of Guardant Health I - GuruFocus
Is Guardant Health Inc. (5GH) stock in buy zone after pullbackJuly 2025 Highlights & Reliable Breakout Forecasts - newser.com
Guardant Health director Tariq Musa sells $11,165 in stock - Investing.com
Guardant Health Director Tariq Musa Sells Shares - TradingView
Dir Tariq Sells 116 ($11.2K) Of Guardant Health Inc [GH] - TradingView
Guardant Health Stock Soars with Blood Test Expansion and Strong Q3 Results - StocksToTrade
Guardant Health Stock Skyrockets After Q3 Revenue Overhaul - timothysykes.com
Sentiment analysis tools applied to Guardant Health Inc.July 2025 Action & Risk Controlled Stock Alerts - newser.com
Will Guardant Health Inc. stock recover faster than marketRecession Risk & Fast Exit/Entry Strategy Plans - newser.com
How Guardant Health Inc. (5GH) stock compares with top peersWeekly Trade Analysis & Safe Swing Trade Setups - newser.com
Relative strength of Guardant Health Inc. in sector analysisPortfolio Performance Summary & High Accuracy Buy Signal Tips - newser.com
Why Guardant Health Inc. (5GH) stock is trending on social mediaVolume Spike & AI Driven Price Forecasts - newser.com
Key metrics from Guardant Health Inc.’s quarterly dataQuarterly Trade Summary & Long-Term Capital Growth Strategies - newser.com
Dir Tariq Files To Sell 116 Of Guardant Health Inc [GH] - TradingView
Guardant Health stock reaches 52-week high at 103.4 USD By Investing.com - Investing.com Nigeria
Why Guardant Health Inc. stock is recommended by analysts2025 Price Action Summary & Reliable Entry Point Trade Alerts - newser.com
Can momentum traders help lift Guardant Health Inc.Portfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
How supply shortages influence Guardant Health Inc. (5GH) stockBreakout Watch & Technical Entry and Exit Tips - newser.com
Guardant Health stock reaches 52-week high at 103.4 USD - Investing.com
Is Guardant Health Inc. (5GH) stock a fit for income portfoliosJuly 2025 Trends & Stepwise Trade Signal Implementation - newser.com
Will Guardant Health Inc. stock split again soonQuarterly Portfolio Report & Breakout Confirmation Trade Signals - newser.com
Guardant Health at Jefferies: Promising Growth in Cancer Screening By Investing.com - Investing.com Canada
Can Guardant Health Inc. stock sustain institutional interest2025 Key Lessons & AI Forecasted Entry and Exit Points - newser.com
Guardant Health Stock Surges 47% In A Single Month, Wait For A Dip To Buy The Stock - Trefis
Finanzdaten der Guardant Health Inc-Aktie (GH)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.35%
1.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):